1Sahn SA. Management of malignant pleural effusion[J ]. Monaldi Arch Chest Dis,2001,56(5) :394-399
2Sahin U, Unlu M, Akkaya A, et al. The value of small - bore catheter thoracostomy in the treatment of malignant pleural effusions[ J ]. Respiration, 2001,68 (5): 501-505
3Putnam JB Jr,Walsh GL,Swisher SG,et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter[J]. Ann Thorac Surg,2000,69(2) :369-375
4O Driscoll L,Linehan R,M Kennedy S,et al.Lack of prognostic significance of survivin,surviving-deltaEx3,surviving-2B,galectin 3,bag alpha and MRP-1 mRNAS in breast cancer [ J ].Cancer Lett,2003;201(2):225 ～ 36
5Nooter K,Brutel de la Riviere G,Look MP,et al.The prognostic significance of the multidrug resistance-associated protein (MRP) in primary breast cancer [J].Br J Cancer,1997;76(4):486 ～ 93
6Rozelle M Harvie,Mary W Davey,Ross A Davey,et al.Increased MRP expression is associated with resistance to radiation,anthracyclinesand etoposide in cells treated with fractionated γ-radiation [ J].Int J Cancer,1997;73:164～ 167
